Antonio Perrella
Ospedale Misericordia - Grosseto(IT)Azienda Usl Toscana Centro(IT)
Publications by Year
Research Areas
Asthma and respiratory diseases, SARS-CoV-2 and COVID-19 Research, Respiratory and Cough-Related Research, COVID-19 Clinical Research Studies, Chronic Obstructive Pulmonary Disease (COPD) Research
Most-Cited Works
- → JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality(2020)215 cited
- → Factors reducing omalizumab response in severe asthma(2018)64 cited
- → Effects of omalizumab in severe asthmatics across ages: A real life Italian experience(2016)37 cited
- → Can the response to Omalizumab be influenced by treatment duration? A real-life study(2017)15 cited
- → Spontaneous abdominal bleeding associated with SARS-CoV-2 infection: causality or coincidence?(2021)11 cited
- → Smoking and Obesity Increase Airway Hyperesponsiveness Risk in the Elderly(2016)10 cited
- → Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes(2019)8 cited
- → Which LABA/LAMA should be chosen in COPD patients in real life?(2021)7 cited
- → COVID-19 severity appears to be reduced in spring/summer.(2023)4 cited
- → Triple Therapy in COPD in Real Life: Is It Better to Use Single or Multiple Inhalers?(2024)3 cited